Genome-wide association study of circulating estradiol, testosterone, and sex hormone-binding globulin in postmenopausal women.

Genome-wide association studies (GWAS) have successfully identified common genetic variants that contribute to breast cancer risk. Discovering additional variants has become difficult, as power to detect variants of weaker effect with present sample sizes is limited. An alternative approach is to lo...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Jennifer Prescott, Deborah J Thompson, Peter Kraft, Stephen J Chanock, Tina Audley, Judith Brown, Jean Leyland, Elizabeth Folkerd, Deborah Doody, Susan E Hankinson, David J Hunter, Kevin B Jacobs, Mitch Dowsett, David G Cox, Douglas F Easton, Immaculata De Vivo
Formato: article
Lenguaje:EN
Publicado: Public Library of Science (PLoS) 2012
Materias:
R
Q
Acceso en línea:https://doaj.org/article/b65522c5872b4fa2a841f3c50e149063
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
id oai:doaj.org-article:b65522c5872b4fa2a841f3c50e149063
record_format dspace
spelling oai:doaj.org-article:b65522c5872b4fa2a841f3c50e1490632021-11-18T07:16:30ZGenome-wide association study of circulating estradiol, testosterone, and sex hormone-binding globulin in postmenopausal women.1932-620310.1371/journal.pone.0037815https://doaj.org/article/b65522c5872b4fa2a841f3c50e1490632012-01-01T00:00:00Zhttps://www.ncbi.nlm.nih.gov/pmc/articles/pmid/22675492/pdf/?tool=EBIhttps://doaj.org/toc/1932-6203Genome-wide association studies (GWAS) have successfully identified common genetic variants that contribute to breast cancer risk. Discovering additional variants has become difficult, as power to detect variants of weaker effect with present sample sizes is limited. An alternative approach is to look for variants associated with quantitative traits that in turn affect disease risk. As exposure to high circulating estradiol and testosterone, and low sex hormone-binding globulin (SHBG) levels is implicated in breast cancer etiology, we conducted GWAS analyses of plasma estradiol, testosterone, and SHBG to identify new susceptibility alleles. Cancer Genetic Markers of Susceptibility (CGEMS) data from the Nurses' Health Study (NHS), and Sisters in Breast Cancer Screening data were used to carry out primary meta-analyses among ~1600 postmenopausal women who were not taking postmenopausal hormones at blood draw. We observed a genome-wide significant association between SHBG levels and rs727428 (joint β = -0.126; joint P = 2.09 × 10(-16)), downstream of the SHBG gene. No genome-wide significant associations were observed with estradiol or testosterone levels. Among variants that were suggestively associated with estradiol (P<10(-5)), several were located at the CYP19A1 gene locus. Overall results were similar in secondary meta-analyses that included ~900 NHS current postmenopausal hormone users. No variant associated with estradiol, testosterone, or SHBG at P<10(-5) was associated with postmenopausal breast cancer risk among CGEMS participants. Our results suggest that the small magnitude of difference in hormone levels associated with common genetic variants is likely insufficient to detectably contribute to breast cancer risk.Jennifer PrescottDeborah J ThompsonPeter KraftStephen J ChanockTina AudleyJudith BrownJean LeylandElizabeth FolkerdDeborah DoodySusan E HankinsonDavid J HunterKevin B JacobsMitch DowsettDavid G CoxDouglas F EastonImmaculata De VivoPublic Library of Science (PLoS)articleMedicineRScienceQENPLoS ONE, Vol 7, Iss 6, p e37815 (2012)
institution DOAJ
collection DOAJ
language EN
topic Medicine
R
Science
Q
spellingShingle Medicine
R
Science
Q
Jennifer Prescott
Deborah J Thompson
Peter Kraft
Stephen J Chanock
Tina Audley
Judith Brown
Jean Leyland
Elizabeth Folkerd
Deborah Doody
Susan E Hankinson
David J Hunter
Kevin B Jacobs
Mitch Dowsett
David G Cox
Douglas F Easton
Immaculata De Vivo
Genome-wide association study of circulating estradiol, testosterone, and sex hormone-binding globulin in postmenopausal women.
description Genome-wide association studies (GWAS) have successfully identified common genetic variants that contribute to breast cancer risk. Discovering additional variants has become difficult, as power to detect variants of weaker effect with present sample sizes is limited. An alternative approach is to look for variants associated with quantitative traits that in turn affect disease risk. As exposure to high circulating estradiol and testosterone, and low sex hormone-binding globulin (SHBG) levels is implicated in breast cancer etiology, we conducted GWAS analyses of plasma estradiol, testosterone, and SHBG to identify new susceptibility alleles. Cancer Genetic Markers of Susceptibility (CGEMS) data from the Nurses' Health Study (NHS), and Sisters in Breast Cancer Screening data were used to carry out primary meta-analyses among ~1600 postmenopausal women who were not taking postmenopausal hormones at blood draw. We observed a genome-wide significant association between SHBG levels and rs727428 (joint β = -0.126; joint P = 2.09 × 10(-16)), downstream of the SHBG gene. No genome-wide significant associations were observed with estradiol or testosterone levels. Among variants that were suggestively associated with estradiol (P<10(-5)), several were located at the CYP19A1 gene locus. Overall results were similar in secondary meta-analyses that included ~900 NHS current postmenopausal hormone users. No variant associated with estradiol, testosterone, or SHBG at P<10(-5) was associated with postmenopausal breast cancer risk among CGEMS participants. Our results suggest that the small magnitude of difference in hormone levels associated with common genetic variants is likely insufficient to detectably contribute to breast cancer risk.
format article
author Jennifer Prescott
Deborah J Thompson
Peter Kraft
Stephen J Chanock
Tina Audley
Judith Brown
Jean Leyland
Elizabeth Folkerd
Deborah Doody
Susan E Hankinson
David J Hunter
Kevin B Jacobs
Mitch Dowsett
David G Cox
Douglas F Easton
Immaculata De Vivo
author_facet Jennifer Prescott
Deborah J Thompson
Peter Kraft
Stephen J Chanock
Tina Audley
Judith Brown
Jean Leyland
Elizabeth Folkerd
Deborah Doody
Susan E Hankinson
David J Hunter
Kevin B Jacobs
Mitch Dowsett
David G Cox
Douglas F Easton
Immaculata De Vivo
author_sort Jennifer Prescott
title Genome-wide association study of circulating estradiol, testosterone, and sex hormone-binding globulin in postmenopausal women.
title_short Genome-wide association study of circulating estradiol, testosterone, and sex hormone-binding globulin in postmenopausal women.
title_full Genome-wide association study of circulating estradiol, testosterone, and sex hormone-binding globulin in postmenopausal women.
title_fullStr Genome-wide association study of circulating estradiol, testosterone, and sex hormone-binding globulin in postmenopausal women.
title_full_unstemmed Genome-wide association study of circulating estradiol, testosterone, and sex hormone-binding globulin in postmenopausal women.
title_sort genome-wide association study of circulating estradiol, testosterone, and sex hormone-binding globulin in postmenopausal women.
publisher Public Library of Science (PLoS)
publishDate 2012
url https://doaj.org/article/b65522c5872b4fa2a841f3c50e149063
work_keys_str_mv AT jenniferprescott genomewideassociationstudyofcirculatingestradioltestosteroneandsexhormonebindingglobulininpostmenopausalwomen
AT deborahjthompson genomewideassociationstudyofcirculatingestradioltestosteroneandsexhormonebindingglobulininpostmenopausalwomen
AT peterkraft genomewideassociationstudyofcirculatingestradioltestosteroneandsexhormonebindingglobulininpostmenopausalwomen
AT stephenjchanock genomewideassociationstudyofcirculatingestradioltestosteroneandsexhormonebindingglobulininpostmenopausalwomen
AT tinaaudley genomewideassociationstudyofcirculatingestradioltestosteroneandsexhormonebindingglobulininpostmenopausalwomen
AT judithbrown genomewideassociationstudyofcirculatingestradioltestosteroneandsexhormonebindingglobulininpostmenopausalwomen
AT jeanleyland genomewideassociationstudyofcirculatingestradioltestosteroneandsexhormonebindingglobulininpostmenopausalwomen
AT elizabethfolkerd genomewideassociationstudyofcirculatingestradioltestosteroneandsexhormonebindingglobulininpostmenopausalwomen
AT deborahdoody genomewideassociationstudyofcirculatingestradioltestosteroneandsexhormonebindingglobulininpostmenopausalwomen
AT susanehankinson genomewideassociationstudyofcirculatingestradioltestosteroneandsexhormonebindingglobulininpostmenopausalwomen
AT davidjhunter genomewideassociationstudyofcirculatingestradioltestosteroneandsexhormonebindingglobulininpostmenopausalwomen
AT kevinbjacobs genomewideassociationstudyofcirculatingestradioltestosteroneandsexhormonebindingglobulininpostmenopausalwomen
AT mitchdowsett genomewideassociationstudyofcirculatingestradioltestosteroneandsexhormonebindingglobulininpostmenopausalwomen
AT davidgcox genomewideassociationstudyofcirculatingestradioltestosteroneandsexhormonebindingglobulininpostmenopausalwomen
AT douglasfeaston genomewideassociationstudyofcirculatingestradioltestosteroneandsexhormonebindingglobulininpostmenopausalwomen
AT immaculatadevivo genomewideassociationstudyofcirculatingestradioltestosteroneandsexhormonebindingglobulininpostmenopausalwomen
_version_ 1718423688887402496